Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NT5E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CAND1.11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC102800447 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SCN7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM46C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EID3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LUZP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FZD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC1A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCF5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDHA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on